CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $69,342
- in 1 filing
Net −$69,342. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-17 | BAKER BROS. ADVISORS LP Director | Purchase | +7,612 | $31.83 | $242K | 38,162,486 |
| 2020-03-17 | BAKER BROS. ADVISORS LP Director | Purchase | +2,676 | $32.19 | $86K | 3,448,760 |
| 2020-03-17 | BAKER BROS. ADVISORS LP Director | Purchase | +29,624 | $32.19 | $954K | 38,192,110 |
| 2020-03-17 | BAKER BROS. ADVISORS LP Director | Purchase | +2,188 | $32.32 | $71K | 3,450,948 |
| 2020-03-17 | BAKER BROS. ADVISORS LP Director | Purchase | +24,223 | $32.32 | $783K | 38,216,333 |
| 2020-03-17 | BAKER BROS. ADVISORS LP Director | Purchase | +8,402 | $33.86 | $285K | 3,459,350 |
| 2020-03-17 | BAKER BROS. ADVISORS LP Director | Purchase | +93,006 | $33.86 | $3.1M | 38,309,339 |
| 2020-03-16 | BAKER BROS. ADVISORS LP Director | Purchase | +497 | $31.19 | $15K | 3,384,118 |
| 2020-03-16 | BAKER BROS. ADVISORS LP Director | Purchase | +5,503 | $31.19 | $172K | 37,476,468 |
| 2020-03-16 | BAKER BROS. ADVISORS LP Director | Purchase | +57,022 | $31.51 | $1.8M | 3,441,140 |
| 2020-03-16 | BAKER BROS. ADVISORS LP Director | Purchase | +631,281 | $31.51 | $19.9M | 38,107,749 |
| 2020-01-07 | Brege Laura Director | Option exercise | +10,000 | $1.75 | $18K | 10,000 |
| 2020-01-07 | Brege Laura Director | Sale | −10,000 | $42.19 | $422K | 0 |
| 2020-01-07 | Brege Laura Director | Option exercise · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2020-01-06 | YANG MICHAEL J. EVP and CCO | Grant or award · Stock Options (Right to Buy) | +39,516 | 39,516 | ||
| 2020-01-06 | YANG MICHAEL J. EVP and CCO | Grant or award · Restricted Stock Units | +10,889 | 10,889 | ||
| 2020-01-06 | Ridloff Elena EVP and CFO | Grant or award · Stock Options (Right to Buy) | +39,516 | 39,516 | ||
| 2020-01-06 | Ridloff Elena EVP and CFO | Grant or award · Restricted Stock Units | +10,889 | 10,889 | ||
| 2020-01-06 | KIM AUSTIN D. EVP & General Counsel | Grant or award · Stock Options (Right to Buy) | +23,709 | 23,709 | ||
| 2020-01-06 | KIM AUSTIN D. EVP & General Counsel | Grant or award · Restricted Stock Units | +6,533 | 6,533 |
Page 40 of 63 · 1,260 trades